Real-time enrollment status for this alzheimer's disease clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 7:39 AM UTC
| NCT Number | NCT07105709 |
| Recruiting Status | Recruiting |
| Condition | Alzheimer's Disease |
| Phase | Clinical Trial |
| Target Enrollment | 220 participants |
| Active Locations | 9 sites in the US |
| Sponsor | GlaxoSmithKline |
| Last Updated on CT.gov | February 2, 2026 (Feb 2, 2026) |
As of July 13, 2026: Clinical trial NCT07105709 is currently recruiting participants. This clinical trial study for alzheimer's disease is actively seeking new participants at 9 locations across the United States. The study is sponsored by GlaxoSmithKline. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07105709 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 9 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07105709 was last updated Feb 2, 2026 (February 2, 2026). HelloStudys verifies this status automatically.